Congratulations to Emory’s infectious diseases program, which has been ranked number five in the United States and number nine worldwide by U.S. News & World Report. This external accolade just confirms what we already know: Emory is a global leader in the research and treatment of infectious diseases. We appreciate this well-deserved honor for our infectious diseases staff, researchers, and clinicians, who have been making a phenomenal impact in this lifesaving discipline for many years.
Emory continues to lead the way in tackling some of the world’s most devastating diseases, including HIV and Ebola. Most recently, our teams have also been at the forefront of clinical trials for COVID-19 vaccines and therapeutics, including ones that are currently being administered to millions of Americans.
I’d also like to acknowledge several teams which have proven foundational for Emory’s preeminence in infectious diseases research, including the Divisions of Infectious Diseases in the Departments of Medicine and Pediatrics, our programs in infectious diseases in the Departments of Pathology and Microbiology and Immunology, our infectious diseases drug discovery programs, the Emory Vaccine Center, the Yerkes National Primate Center, the Emory Center for AIDS Research, and the Serious Communicable Diseases Unit, as well as the many other faculty and staff across Emory who are involved in infectious diseases pathogenesis, diagnosis, treatment and prevention.
To all who are involved in making our infectious diseases program the world leader it is today, please accept my heartfelt congratulations and my deepest thanks.
Please direct questions and comments to evphafeedback@emory.edu.
Jonathan S. Lewin, MD, FACR Executive Vice President for Health Affairs, Emory University Executive Director, Woodruff Health Sciences Center CEO and Chairman of the Board, Emory Healthcare |